# FDA Inspection 851827 - Shandong Anhong Pharmaceutical Co., Ltd. - September 13, 2013

Source: https://www.keypedia.com/records/fda_inspections/shandong-anhong-pharmaceutical-co-ltd/9eebdc22-c7de-465a-9517-088e8bd43b53
Source feed: FDA_Inspections

> FDA Inspection 851827 for Shandong Anhong Pharmaceutical Co., Ltd. on September 13, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 851827
- Company Name: Shandong Anhong Pharmaceutical Co., Ltd.
- Inspection Date: 2013-09-13
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1081775 - 2019-02-22](https://www.keypedia.com/records/fda_inspections/shandong-anhong-pharmaceutical-co-ltd/8b8439c6-6656-45ee-aba1-007a022eb5f5)
- [FDA Inspection 983627 - 2016-09-02](https://www.keypedia.com/records/fda_inspections/shandong-anhong-pharmaceutical-co-ltd/49ead6f2-67d4-4179-98a0-75536c335df6)

Company: https://www.keypedia.com/companies/shandong-anhong-pharmaceutical-co-ltd/3b784225-cf8c-4bc5-a5ad-b5e47f484f59

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c